InsidersTradesSigma
Explore the full record of transactions filed by Apel Daniel Joseph, Chief Financial Officer. Insider active across 1 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 2 disclosures have been published. Total volume traded: €384k. The latest transaction was disclosed on 22 April 2026 — Cession. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Daniel Joseph Apel is the Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. He oversees financial operations and contributes to the overall strategy of the company.